| Dr Jason Troiano, MD | |
|
101 Donald Ross Dr, Raleigh, NC 27610-2593 | |
| (919) 250-3320 | |
| Not Available |
| Full Name | Dr Jason Troiano |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | 101 Donald Ross Dr, Raleigh, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023146677 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 200001442 (North Carolina) | Primary |
| Entity Name | Duke University Affiliated Physicians Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316975972 PECOS PAC ID: 3779489588 Enrollment ID: O20031211000642 |
News Archive
BioTime, Inc. announced today that it has initiated shipments of stem cell research products to its worldwide distributor, Millipore Corporation, according to the terms of the co-marketing agreement between the two companies that was announced on July 9, 2009. BioTime has shipped inventory of six ACTCellerate™ progenitor cell lines to Millipore and plans to begin shipments of additional cell lines and ESpan™ cell growth media in the next several weeks.
Hearing the doorbell, the fire alarm or a tap that has not been properly turned off are everyday situations that can become a problem for a person who is hard of hearing.
For the first time, scientists at Children's National Medical Center have successfully identified a key developmental program for the amygdala-the part of the limbic system that impacts how the brain creates emotional memories and responses.
Results of a new study in non-small cell lung cancer showed that patients with specific oncogenic rearrangements of the anaplastic lymphoma kinase (ALK) gene within the short arm of chromosome 2 of their tumors had a much greater response to a new therapy - an ALK-inhibitor.
AstraZeneca today reported new Phase I extended follow-up data on osimertinib in both first- and second-line treatment of patients with non-small cell lung cancer (NSCLC), at the European Lung Cancer Conference (ELCC) 2016. Late-breaker presentations reinforced the efficacy and safety profile for osimertinib previously seen in the AURA clinical trials programme.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason Troiano, MD 2815 Cates Ave, Raleigh, NC 27695-7304 Ph: (919) 515-2563 | Dr Jason Troiano, MD 101 Donald Ross Dr, Raleigh, NC 27610-2593 Ph: (919) 250-3320 |
News Archive
BioTime, Inc. announced today that it has initiated shipments of stem cell research products to its worldwide distributor, Millipore Corporation, according to the terms of the co-marketing agreement between the two companies that was announced on July 9, 2009. BioTime has shipped inventory of six ACTCellerate™ progenitor cell lines to Millipore and plans to begin shipments of additional cell lines and ESpan™ cell growth media in the next several weeks.
Hearing the doorbell, the fire alarm or a tap that has not been properly turned off are everyday situations that can become a problem for a person who is hard of hearing.
For the first time, scientists at Children's National Medical Center have successfully identified a key developmental program for the amygdala-the part of the limbic system that impacts how the brain creates emotional memories and responses.
Results of a new study in non-small cell lung cancer showed that patients with specific oncogenic rearrangements of the anaplastic lymphoma kinase (ALK) gene within the short arm of chromosome 2 of their tumors had a much greater response to a new therapy - an ALK-inhibitor.
AstraZeneca today reported new Phase I extended follow-up data on osimertinib in both first- and second-line treatment of patients with non-small cell lung cancer (NSCLC), at the European Lung Cancer Conference (ELCC) 2016. Late-breaker presentations reinforced the efficacy and safety profile for osimertinib previously seen in the AURA clinical trials programme.
› Verified 7 days ago
Conrad Flick, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3500 Bush St, Raleigh, NC 27609 Phone: 919-875-8150 Fax: 919-875-9577 | |
Dr. Christopher Zaguirre Rayala, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 150 E Davie St, Raleigh, NC 27601 Phone: 919-834-5299 | |
Dr. Mona Soliman, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11200 Governor Manly Way, Raleigh, NC 27614 Phone: 919-570-7700 | |
Douglas Ira Hammer, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1207 Watauga St, Raleigh, NC 27604 Phone: 919-215-5078 | |
William Grant Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11200 Governor Manly Way, Raleigh, NC 27614 Phone: 919-747-5270 Fax: 919-747-5271 | |
Mrs. Soenda P Norman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10211 Alm St, Suite 1200, Raleigh, NC 27617 Phone: 919-206-4889 Fax: 919-206-4875 |